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Background: The need for ways to minimize the number of implantable cardioverter-deﬁbrillator (ICD)
shocks is increasing owing to the risk of its adverse effects on life expectancy. Studies have shown that a
longer detection time for ventricular tachyarrhythmia reduces the safety of therapies, in terms of
syncope and mortality, but not substantially in terms of the success rate. We aimed to evaluate the effects
of increased number of intervals to detect (NID) VF on the safety of ICD shock therapy and on the
reduction of inappropriate shocks.
Methods: The present study was a prospective, multicenter, randomized, crossover study. Randomized
VF induction testing with NID 18/24 or 30/40 was performed to compare the success rate of deﬁbrillation
with a 25-J shock and the time to detection. Inappropriate shock episodes were simulated retrospectively
to evaluate a possibility of episodes avoidable at NID 24/32 and 30/40.
Results: Thirty-one consecutive patients implanted with an ICD or cardiac resynchronization therapy-
deﬁbrillator (CRT-D) were enrolled in this study. The success rate of deﬁbrillation was 100% in both NID
groups at the ﬁrst shock. The time from VF induction to detection showed a signiﬁcant increase in the
NID 30/40 group (6.1671.29 s vs. 9.0071.31 s, po0.001). Among the 120 patients implanted with an
ICD or CRT-D, 10 experienced 32 inappropriate shock episodes. The inappropriate shock reduction rate
was 53.1% and 62.5% with NID 24/32 and 30/40, respectively.
Conclusions: The ﬁndings of this SANKS study suggest that VF NID 30/40 does not compromise the safety
of ICD shock therapy, while decreasing the number of inappropriate shocks.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
The implantable cardioverter-deﬁbrillator (ICD) can prevent
sudden cardiac death; however, recent studies have reported that
ICD shock therapy, whether appropriate or inappropriate, may
reduce the life expectancy of ICD recipients [1–3]. Inappropriate
and unnecessary shock delivery is attributable to each ICD device's
algorithm for detecting ventricular tachyarrhythmia (VTA). One
algorithm detects VTA when a certain number of beats in the
detection zone reaches the pre-programmed number of intervals
to detect (NID). Many studies have explored ways to avoid
inappropriate and unnecessary ICD shocks for fast ventricular
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tachycardia (FVT). Some have reported that increasing NID and
using antitachycardia pacing (ATP) effectively avoids inappropriate
and unnecessary ICD shocks for FVT [4–10]. In the case of
ventricular ﬁbrillation (VF), increased NID may prolong the time
to shock therapy and pose higher risks of hemodynamic deteriora-
tion and unstable VF waves, resulting in a higher number of
undersensed VFs and higher deﬁbrillation thresholds [11,12].
However, very few studies have evaluated the inﬂuence of pro-
longed time to shock therapy on the safety of ICD shock therapy.
This SANKS study evaluated the effects of increased NID in the VF
detection zone (VF NID) on the safety of ICD shock therapy and the
number of inappropriate ICD shocks.
2. Material and methods
2.1. Study design
This SANKS study consisted of two aspects. One was a pro-
spective, multicenter, randomized, un-blinded, crossover study to
evaluate the safety of ICD shock therapy with increased VF NID in
the VF detection zone. The other was a retrospective study to
assess the possibility of reducing shocks with increased VF NID.
For the safety evaluation, we examined the deﬁbrillation
success rate, time from detection to termination, undersensing of
VTA, and adverse events related to ICD shock therapy during
induction testing. This study design is shown in Fig. 1. The subjects
were patients eligible for implantation of a commercially available
Medtronic ICD or cardiac resynchronization therapy-deﬁbrillator
(CRT-D) for primary or secondary prevention. At the time of
implantation, subjects were randomly assigned to 1 of the 2 VF
NID settings in a 1:1 ratio: (1) NID 18/24 (18 of the last 24 beats in
the VF detection zone must meet a programmable threshold rate
for the device to detect and treat) or (2) NID 30/40. During the ﬁrst
and second VF induction tests, the patients were crossed over to
the other setting so that the safety of each NID setting could be
evaluated. Inherently, VF NID 30/40 will take longer to detect an
arrhythmia because it requires at least 16 more beats.
We also evaluated the possibility of shock reduction with pro-
longed detection duration, NID 24/32 or NID 30/40, by computer
simulation retrospectively. This analysis used spontaneous shock
episodes from a separate sample of subjects who previously received
an ICD or CRT-D programmed to NID 18/24.
2.2. Participants
The study was conducted at three sites in Japan. Subjects enrolled
for the safety evaluation met the following eligibility criteria: Class I
or IIa recommendation for ICD or CRT-D implantation by the Guide-
lines for Non-Pharmacotherapy of Cardiac Arrhythmias (Japanese
Circulation Society) [13]; a history of cardiac events; patients
medically cleared to receive VF induction testing; and patients able
to tolerate 25-J shocks at VF induction testing. For medical reasons,
patients not able to undergo VF induction testing were excluded.
Written informed consent was obtained from all subjects prior to
participation in the study.
The same study sites participated in the computer simulation
to evaluate the possibility of shock reduction. Spontaneous shock
episodes from the subjects who underwent implantation of an ICD
or CRT-D between March 2001 and March 2008 were used in the
simulation.
2.3. End-points
End-points 1–3 were evaluated in the randomized induction
study. End-point 4 was analyzed via retrospective computer
simulation.
2.3.1. Deﬁbrillation success rates
After randomization, the subjects in both groups received a VF
induction. Five minutes later, they were crossed over to the other
NID setting and received a second VF induction. The deﬁbrillation
success rate was evaluated for each NID setting. The ICD was set to
deliver a 25-J shock, 10 J below the maximum shock energy for the
Fig. 1. Study ﬂow diagram for the randomized study. ICD, implantable cardioverter-deﬁbrillator; CRT-D, cardiac resynchronization therapy-deﬁbrillator; NID, number of
intervals to detect; VF, ventricular ﬁbrillation.
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device. Successful termination of the induced arrhythmia by the
25-J shock implied success.
2.3.2. Time measurement
The times from VF induction to detection, from VF detection to
termination, and from VF induction to termination were measured
for each NID setting.
2.3.3. Undersensing
The number of undersensed VTAs during detection was counted
for each NID setting. The inﬂuence of cardiac dysfunction on the
number was determined using the following 2 patient groups:
patients with left ventricular ejection fraction (LVEF) o40% and those
with LVEF Z40%. The sensitivity was set at 1.2 mV for VF induction
testing. Undersensing was deﬁned as a failure of the ICD to mark a
relevant peak on its electrogram (EGM). The number of unmarked
EGM peaks was considered the number of undersensed VTAs.
2.3.4. Shock reduction rate
The inappropriate shock reduction rate was evaluated by
modeling NID 24/32 and NID 30/40. ICD EGMs were retrospec-
tively reviewed from subjects previously implanted with an ICD or
CRT-D that was programmed to NID 18/24. Inappropriate sponta-
neous shock episodes with no ATP therapies applied were used for
the analysis. The EGM data that included all intervals during these
episodes was loaded into a VIP II simulator (Medtronic Inc.) to
determine whether the shock could have been avoided if the NID
was 24/32 or 30/40. In other words, would the device not have
detected and treated the episode had the NID been set to 24/32 or
30/40 instead of 18/24?
This study was performed in compliance with the Declaration
of Helsinki and its conduct was approved by the Institutional
Review Board or Medical Ethics Committee of each study site
(UMIN registration number: UMIN000003442).
2.4. Statistical methods
Continuous variables are reported as the mean7standard
deviation (SD). The deﬁbrillation success rate was calculated as
the percentage of VTA terminated by 25-J shocks. A paired t-test
was performed for time comparisons between NID 18/24 and NID
30/40. The number of undersensed peaks between low and normal
cardiac function was compared using the Wilcoxon rank-sum test.
Spearman's rank correlation was used to quantify the variation in
the number of undersensed VTAs with time. A value of po0.05
was considered statistically signiﬁcant. Analysis was performed
with SPSS version 19 statistical software (SPSS Inc., Chicago,
Illinois).
3. Results
Thirty-one patients were enrolled consecutively, in this rando-
mized study, between January 2010 and March 2012. The mean
age was 65.5713.7 years. The proportion of patients with primary
prevention indication was 25.8% and ischemic cardiomyopathy
was 29.0%. All reported patient characteristics are shown in
Table 1. Among the consecutive patients, 5 patients were excluded
from this study for the following conditions: 2 patients were
excluded for old age, 1 patient, for deteriorated general condition
due to cancer, and the last 2 patients, for low cardiac function.
The retrospective analysis included 120 patients previously
implanted with an ICD or CRT-D. Thirty-two inappropriate shock
episodes that occurred in 10 (8.3%) of the 120 patients were analyzed.
3.1. Success rate of ICD shocks
All subjects underwent VF induction testing. Of the 62 induced
VTAs, 54 episodes were adjudicated as VF by the investigators and
8 were ventricular tachycardia (VT) with an average cycle length of
287783 ms. The success rate of terminating VTA by the ﬁrst ICD
shock was 100% in both the NID 18/24 and NID 30/40 groups,
without any related complications.
3.2. Time from VF induction to detection or termination
The time from VF induction to detection was higher in the NID
30/40 group (9.0071.31 s) than that in the NID 18/24 group
(6.1671.29 s; po0.001). The time from VF detection to termina-
tion did not differ between the 2 groups (p¼0.62), whereas the
time from VF induction to termination did show a signiﬁcant
increase in the NID 30/40 group (13.4871.26 s) as compared to
the NID 18/24 group (10.6171.33 s, po0.001; Table 2 and Fig. 2).
Table 1
Baseline characteristics of the prospective cohort (n¼31).
Age (years) 65.5 (13.7)
Male gender 27 (87.1%)
Underlying heart disease
Ischemic 9 (29.0%)
Dilated cardiomyopathy 7 (22.6%)
Hypertrophic cardiomyopathy 2 (6.5%)
Brugada syndrome 4 (12.9%)
Long QT syndrome 1 (3.2%)
Idiopathic VF 1 (3.2%)
Other 7 (22.6%)
Primary prevention 8 (25.8%)
LVEDD (mm) 55.7 (11.1)
LVESD (mm) 42.2 (14.0)
LVEF (%) 47.1 (16.5)
Medication
ACE inhibitor 5 (16.1%)
ARB 14 (45.2%)
Beta-blocker 19 (61.3%)
Anti-arrhythmic 13 (41.9%)
Calcium antagonist 6 (19.4%)
Other AAD 5 (16.1%)
AAD, anti-arrhythmic drugs; ARB, angiotensin receptor blocker; ACE, angiotensin
converting enzyme; LVEDD, left ventricular end diastolic diameter; LVEF, left
ventricular ejection fraction; LVESD, left ventricular end systolic diameter. Data
are presented as mean values (standard deviation) or numbers (%).
Table 2
Time from VF induction to detection or termination.
Group Time (s) Time difference (s) p-Value
Time to detection from induction (s)
NID: 18/24 6.1671.29 2.8471.29 o0.001
NID: 30/40 9.0071.31
Time to termination from detection (s)
NID: 18/24 4.4570.19 0.0370.30 0.62
NID: 30/40 4.4870.25
Time to termination from induction (s)
NID: 18/24 10.6171.33 2.8771.39 o0.001
NID: 30/40 13.4871.26
NID, number of intervals to detect; VF, ventricular ﬁbrillation. Data are presented as
mean7standard deviation.
M. Noro et al. / Journal of Arrhythmia 31 (2015) 94–10096
3.3. Undersensing
There was no difference in the number of undersensed VTAs
after VF induction between the groups (NID 18/24; 1.9472.49
peaks vs. NID 30/40; 2.1672.54 peaks, p¼0.78). There was no
correlation between the number of undersensed peaks and time
after VTA induction (NID 18/24; r¼0.24, p¼0.905, NID 30/40;
r¼0.137, p¼0.385) (Fig. 3). No relationship was found between the
number of undersensed peaks and cardiac dysfunction (Table 3).
3.4. Shock reduction rate
The results of the retrospective analysis are shown in Table 4
and Fig. 4. Of the 32 inappropriate shock episodes, 17 and 20 were
avoidable when modeling NID 24/32 and 30/40 (53.1% and 62.5%;
95% conﬁdence interval, 34.7–70.9% and 45.7–79.3%, respectively).
Regarding NID 30/40, the avoidable shock episodes included 5 of
the 5 episodes due to atrial ﬁbrillation (AF, 100%), 1 of the
4 episodes due to supraventricular tachycardia (SVTs, 25.0%), 12
of the 21 episodes due to lead fracture (57.1%), and 2 of the
2 episodes due to P- or T-wave oversensing (100%). With NID 24/30,
there were 3 unavoidable inappropriate shocks. All those shocks
were due to lead fracture.
4. Discussion
While ICD shock therapy has prevented sudden cardiac death,
shock therapy may induce myocardial damage and inﬂuence cardiac
hemodynamics or life expectancy [1–3,14–17]. It has been suggested
that myocardial damage resulting from shock therapy contributes to
poor prognosis, whereas the use of ATP minimizes damage and does
not affect prognosis. It is therefore important to terminate ventricular
arrhythmias with the ﬁrst ICD shock and minimize the number of
inappropriate and unnecessary ICD shocks.
The safety of deﬁbrillation with prolonged detection duration
has been a matter of concern owing to the possibility of deﬁbrilla-
tion threshold (DFT) elevation and creation of unstable VF waves
over time. Windecker et al. noted that VF episodes lasting 10 s or
more may have adverse effects on DFTs and negatively affect the
effectiveness of ICD therapy [11]. Increasing VF NID prolongs the
detection duration and may also cause unstable VF waves, result-
ing in additional undersensed VTAs. This study demonstrated that
NID 30/40 increased the time from VF induction to detection by
2.84 s; however, the deﬁbrillation success rate was 100% by the
ﬁrst ICD shock, and the numbers of undersensed peaks were
similar between both NID groups. Further, in patients with cardiac
dysfunction, smaller VF waves may lead to more undersensed
peaks that could cause prolongation of the time from VF induction
to termination. The present study showed no differences in the
number of undersensed peaks between patients with cardiac
dysfunction and normal cardiac function, even in the NID 30/40
group. These results suggest that VF NID could be increased to 30/
40 in a safe manner, with no effects on the sensitivity to VTA or the
deﬁbrillation success rate.
Current ICD devices have VT/VF discrimination algorithms to
avoid inappropriate ICD shocks (e.g., Sudden Onset, Stability,
Morphology Discrimination), although they cannot completely
Fig. 2. Two implantable cardioverter deﬁbrillator-stored EGMs from VF induction to termination, with 2 NID settings in a patient (18/24 and 30/40). The panel A EGM was
recorded with NID 18/24. The time from VF induction to detection was 4.84 s, and the time from VF detection to termination was 4.55 s; the total time to VF termination was
9.39 s. The panel B EGMwas recorded with NID 30/40. The time from VF induction to detectionwas 7.20 s, and the time from VF detection to termination was 4.57 s; the total
time to VF termination was 11.77 s, 2.38 s longer than that with NID 18/24. EGM, electrogram; NID, number of intervals to detect; VF, ventricular ﬁbrillation; VT, ventricular
tachycardia; FVT, fast ventricular tachycardia.
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discriminate VT/VF from relatively regular AF or SVTs with
aberrant conduction. In the VF detection zone, the use of the
discrimination algorithms is limited. A run of beats in the VF zone
is classiﬁed according to the number of beats when discrimination
algorithms cannot be utilized. Furthermore, ICD rate schemes
often misdiagnose AF or oversense and classify episodes as VF,
thereby increasing the challenge of avoiding inappropriate ICD
shocks in the VF detection zone.
Along with the discrimination algorithms, inappropriate and
unnecessary shocks could be avoided by ATP or ICD programming.
According to the PainFREE and PainFREE Rx II clinical trials, the
ATP success rate in the FVT detection zone (188–250 bpm) was
approximately 70% [4,6]. While ATP therapy may terminate FVT
and avoid unnecessary shocks, it cannot revert VF, which requires
ICD shock therapy. The Primary Prevention Parameters Evaluation
(PREPARE) trial reported that in primary prevention patients,
increased NID (30/40) and ATP attempts for FVTs decreased the
incidence of ICD complications (including appropriate, inappropri-
ate, and unnecessary ICD shocks) without posing safety concerns
and improved the life expectancy of ICD recipients [7]. The
RELEVANT study showed that prolonged detection duration (NID
30/40) led to a dramatic reduction of ICD interventions without
jeopardizing ICD therapy capabilities or increasing morbidity in
primary prevention patients [8]. The MADIT-RIT trial also reported
that ICD programming for high-rate therapy or delayed therapy in
primary prevention patients reduced the occurrence of inap-
propriate therapy [9]. Furthermore, the ADVANCE III study demon-
strated that prolonged detection duration, NID 30/40, could reduce
ICD therapy rate including ATP and shocks in both primary and
secondary prevention patients safely [10]. Although this study is
not exactly comparable to the ADVANCE III study, as ATP therapy
was programmed in the ADVANCE III study, the results of the
present study are in line with those of the ADVANCE III study.
Among the studies described above, the programming of VF
detection interval is different. It still remains unclear how the
detection interval should be programmed; therefore, further
evaluation of the appropriate detection interval and detection
duration is required. In the present study, we aimed to determine
whether increased VF NID (from 18/24 to 24/32 or 30/40) reduced
the number of inappropriate shocks. In the retrospective analysis
of inappropriate shocks, the majority of VF episodes occurred in
the pre-programmed R–R interval, while AF and oversensing
Fig. 3. Variation with time in the number of undersensed ventricular tachyar-
rhythmia from the ﬁrst VF induction to detection (panel A, with NID 18/24; panel B,
NID 30/40). The horizontal axis shows the number of electrogram peaks and the
vertical axis, the number of undersensed peaks in all subjects. No correlation was
found between the duration of the episode and the number of undersensed peaks,
indicating no variation with time. NID, number of intervals to detect; VF,
ventricular ﬁbrillation.
Table 3
The number of undersensed VTAs.
Group The number of undersensed peaks p-Value
Mean Median
NID: 18/24
LVEFZ40% (n¼11) 1.3671.50 1 0.48
LVEFo40% (n¼20) 2.2572.88 1
NID: 30/40
LVEFZ40% (n¼11) 1.6472.46 1 0.36
LVEFo40% (n¼20) 2.4572.61 1.5
LVEF, left ventricular ejection fraction; NID, number of intervals to detect; VTA,
ventricular tachyarrhythmia. Data are presented as mean7standard deviation.
Table 4
Inappropriate shock assessment.
Episode no. Cause of
inappropriate shock
Possible to avoid
with NID 24/32
Possible to avoid
with NID 30/40
1 Oversensing Yes Yes
2 Oversensing Yes Yes
3 AT No No
4 AF Yes Yes
5 AF Yes Yes
6 AF Yes Yes
7 Lead fracture No No
8 Lead fracture Yes Yes
9 Lead fracture No Yes
10 Lead fracture Yes Yes
11 Lead fracture Yes Yes
12 Lead fracture No No
13 Lead fracture No No
14 Lead fracture No No
15 Lead fracture Yes Yes
16 Lead fracture No No
17 Lead fracture No Yes
18 Lead fracture No No
19 Lead fracture Yes Yes
20 AF Yes Yes
21 AT No No
22 ST No No
23 AT Yes Yes
24 AF Yes Yes
25 Lead fracture Yes Yes
26 Lead fracture Yes Yes
27 Lead fracture Yes Yes
28 Lead fracture No No
29 Lead fracture Yes Yes
30 Lead fracture No Yes
31 Lead fracture No No
32 Lead fracture No No
AF, atrial ﬁbrillation; AT, atrial tachycardia; NID, number of intervals to detect;
ST, sinus tachycardia.
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episodes were more likely to deviate from the VF detection zone.
This suggests that increased VF NID is effective in preventing
inappropriate shocks due to AF and oversensing. In this study, all
5 inappropriate shock episodes due to AF were avoidable when
modeling NID 24/32 and 30/40. For instance, in the 5 episodes
with NID 30/40, the maximum number of abnormal beats counted
was 20–27, suggesting the necessity of a longer monitoring time
sufﬁcient to count approximately 30 beats. Since AF is considered
the most common cause of inappropriate shock [1,18], increasing
VF NID would be effective in avoiding these shocks. Furthermore,
the shock reduction rate was 42.9% or 57.1% in the lead fracture
cases with NID 24/32 or 30/40, respectively. Early detection is an
important measure against lead fractures. The Lead Integrity Alert,
which allows such early warnings and prolongs the detection
duration to NID 30/40, has been shown to avoid inappropriate
shocks [19–21]. According to the CONNECT trial [22], the time
from event onset to clinical decision in response to alerts for AT/AF
burden, ventricular rate during AT/AF, and lead impedance out of
range could be signiﬁcantly reduced with a remote monitoring
system. In the future, remote monitoring systems will make it
possible to more effectively avoid inappropriate shock delivery in
addition to the prolonged VF NID approach.
4.1. Limitations
The power of the safety analysis for this study was diminished
by the limited sample size (31 subjects). This was attributed to the
difﬁculty in obtaining informed consent owing to the perceived
risks associated with increased VF NID and the exclusion of
outpatients; this was done to maximize subject safety. Some
patients who could not undergo the DFT test because of their
clinical condition were excluded from this study. However, since
the decision to not undergo a DFT test is not speciﬁc to this study,
we believe that the patient population of this study reﬂects a
representative population. Further, it is unknown if the character-
istics of arrhythmia varied between the ﬁrst and second VF
induction tests, although neither cycle lengths nor wave peaks
differed between the 2 NID groups.
The retrospective analysis of inappropriate shocks had a limited
sample size resulting in a wide conﬁdence interval for the
estimated effect. Device-stored EGM data for each shock episode
is deleted when the shock is delivered. Because of this, it is
possible that the episodes classiﬁed as “inappropriate shock
avoided” with modeled NID 30/40 would have actually resulted
in a shock in a subsequent detection under real-life conditions.
Fig. 4. Inappropriate shocks recorded in implantable cardioverter deﬁbrillator-stored electrograms. (A) An example of atrial ﬁbrillation (black arrows, beats in the VF
detection zone; red arrows, those outside the VF detection zone). An inappropriate shock occurred when the number of VF beats reached VF NID 18/24. With VF NID 30/40,
the number of VF beats was 25/40, and the shock would be avoidable. (B) An example of P- and T-wave oversensing (black arrows, beats in the VF detection zone; red arrows,
beats outside the VF detection zone). An inappropriate shock occurred when the number of VF beats reached VF NID 18/24. With VF NID 30/40, the number of VF beats was
27/40, and the shock was avoidable. NID, number of intervals to detect; VF, ventricular ﬁbrillation.
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5. Conclusion
Although increased VF NID (30/40) prolonged the time to shock
therapy, ICDs terminated all induced VTA episodes within the
safety margin from their maximum shock energy. Inappropriate
ICD shocks were considered to be avoidable with VF NID 30/40.
These ﬁndings support larger studies on this topic, suggesting that
VF NID 30/40 can be used in the clinics to reduce the number of
inappropriate shocks safely.
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